Double alkylating agent therapy with ifosfamide and cyclophosphamide for advanced non-small cell lung cancer. From the Manchester Lung Tumour Group.

Thatcher, N

Double alkylating agent therapy with ifosfamide and cyclophosphamide for advanced non-small cell lung cancer. From the Manchester Lung Tumour Group. [electronic resource] - Cancer Jan 1988 - 14-8 p. digital

Publication Type: Journal Article

0008-543X

10.1002/1097-0142(19880101)61:1<14::aid-cncr2820610104>3.0.co;2-q doi


Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Cyclophosphamide--administration & dosage
Female
Humans
Ifosfamide--administration & dosage
Lung Neoplasms--drug therapy
Male
Middle Aged